期刊文献+

Galectin-3对哮喘豚鼠模型炎性细胞因子和趋化因子的干预作用 被引量:2

Inhibitory Effects of Galectin-3 on the Inflammatory Cytokines and Chemokines in Guinea Pig Asthma Models
下载PDF
导出
摘要 目的 观察哮喘豚鼠模型中白细胞介素- 5 (IL - 5 )、Eotaxin和C- C趋化因子受体3(CCR- 3)在嗜酸粒细胞炎症中的表达和Galectin- 3的干预作用。方法 32只豚鼠随机分为正常对照组、哮喘组、Galectin- 3干预组和地塞米松(DXM)干预组。卵蛋白(OVA)致敏和激发制作哮喘模型,Galectin- 3干预组和DXM干预组分别于致敏后第14~16 d激发前1h腹腔注射Galectin- 3(0 .5 m g/ kg)和DXM(1mg/ kg) ,每日1次。观察血、骨髓涂片,肺组织切片细胞总数和嗜酸粒细胞(EOS)比例。肺组织切片用IL - 5、CCR- 3及Eotaxin多克隆抗体染色,光镜下分别计数阳性细胞比例。结果 与正常对照组相比较,哮喘组豚鼠外周血、骨髓、肺组织中EOS计数显著增加(P<0 .0 5 ) ,肺组织中IL- 5、CCR- 3和Eotaxin阳性细胞比例显著升高(P<0 .0 5 ) ,DXM干预后EOS计数、IL- 5、CCR- 3和Eotaxin阳性细胞比例显著降低(P<0 .0 5 ) ,Galectin- 3干预对EOS计数和IL - 5阳性细胞比例的影响与DXM组相当(P>0 .0 5 ) ;Galectin- 3也可下调CCR- 3阳性细胞的表达(P<0 .0 5 ) ,作用弱于DXM(P<0 .0 5 ) ;但Galectin- 3对Eotaxin水平无显著影响(P>0 .0 5 )。结论 哮喘动物模型肺内IL - 5、Eotaxin及其受体CCR- 3表达增强。Galectin- 3可抑制IL -5表达,轻度下调CCR- 3? Objective To elucidate the roles of interleukin-5 (IL-5),Eotaxin,and CCR-3 in eosinophilic inflammation in guinea pig asthma models and investigate the inhibitory effects of Galectin-3. Methods Thirty-two guinea pigs were randomly assigned to control group,asthma group,Galectin-3 intervention group,and dexamethasone (DXM) intervention group.Asthma models were established by sensitizing-challenging the animals with ovalbumin(OVA).The asthmatic animals were treated with Galectin-3 at 0.5 mg/kg, or DXM at 1 mg/kg,respectively,by peritoneally injection one hour before each aerosol challenge from the 14 th day to 16 th day after sensitization while the control animals were treated with normal saline. The specimens of peripheral blood,bone marrow,and lung tissue on slides were prepared respectively and stained with HE.Then the total number and percentage of eosinophils (EOS) were counted.The lung tissue slide was stained immunochemically with anti-IL-5 polyclonal antibody,anti-Eotaxin polyclonal antibody,and anti-CCR-3 polyclonal antibody,respectively.The immunoactive cells were counted and represented as percentages in total cells. Results The amounts of EOS in peripheral blood,bone marrow,and lung tissue as well as percentages of IL-5,Eotaxin,and CCR-3 immunoactive cells in the lung tissue from asthma group were increased significantly, compared to those from control group.DXM significantly decreased the amounts of EOS,percentages of IL-5,Eotaxin,and CCR-3 immunoactive cells (P<0.05).Galectin-3 had an equivalent suppressive effects on the amounts of EOS and IL-5+ cells with DXM (P>0.05) and down-regulated CCR-3 expression (P<0.05) to a less extent when compared to DXM (P<0.05),but had minimal effect on Eotaxin expression (P>0.05). Conclusion This study provides further evidence for an eosinophil recruitment from bone marrow to circulation blood to lung in asthmatic response,in which over-expression of IL-5,Eotaxin,and CCR-3 could be involved.Galectin-3,a selective inhibitor of IL-5 mRNA transcription,might potentially suppress eosinophilc inflammation and be a compromising specific anti-asthma reagent.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第3期355-358,共4页 Journal of Sichuan University(Medical Sciences)
关键词 哮喘 嗜酸粒细胞 白细胞介素-5 EOTAXIN GALECTIN-3 Asthma Eosinophils Interleukin-5 Eotaxin Galectin-3
  • 相关文献

参考文献11

  • 1Broide D,Sriramarao P.Eosinophil trafficking to sites of allergic inflammation.Immunol Rev,2001;179:163.
  • 2Lilly CM,Nakamura H,Belostotsky OI,et al.Eotaxin expression after segmental allergen challenge in subjects with atopic asthma.Am J Respir Crit Care Med,2001;163(7):1669.
  • 3Victoria del Pozo,Marta Rojo,Maria L.Rubio,et al.Gene therapy with gelectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation.Am J Respir Crit Care Med,2002;166:732.
  • 4Gonzalo JA, Lloyd CM, Wen D, et al.The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.J Exp Med,1998;188(1):157.
  • 5Ying S,meng Q,Zeibecoglou K,et al.C-C chemokines and CCR-3 in asthma.J Immunol,1999;163(11):6321.
  • 6Banwell ME,Tolley NS,Williams TJ,et al.Regulation of human eotaxin-3/CCL26 expression:modulation by cytokines and glucocorticoids.Cytokine,2002;17(6):317.
  • 7Mattoli S,Stacey MA,Sun G,et al.Eotaxin expression and eosinophilic inflammation in asthma.Biochem Biophys Res Commun,1997;236(2):299.
  • 8Brown JR,Kleimberg J,Marini M,et al.Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.Clin Exp Imuunol,1998;114(2):137.
  • 9Uings I,McKinnon M.Development of IL-5 Receptor Antagonists.Curr Pharm Des,2002;8(20):1837.
  • 10Schedvins P,Hjelmstrom P.Chemokines a hope of specific antiinflammatory treatment. Lakartidningen,2002;99(10):1056.

同被引文献17

  • 1郑伟华,李树全,农光民.哮喘豚鼠模型肺泡灌洗液与外周血嗜酸性粒细胞凋亡率及存活率的研究[J].中华儿科杂志,2005,43(9):690-691. 被引量:2
  • 2Walsh GM.Eosinophil apoptosis:mechanisms and clinical relevance in asthmatic and allergic inflammation[J].Br J Haematol,2000,111(1):61-67.
  • 3Dewson G,Cohen GM,Wardlaw AJ.Interleukin-5 inhibits translocation of Bax to the mitochondria,cytochrome c release,and activation of caspases in human eosinophils[J].Blood,2001,98(7):2239-2247.
  • 4Walker C,Bode E,Boer L,et al.Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokines production in peripheral blood and bronchoalveolar lavage[J].Am Rev Respir Dis,1992,146(1):109-115.
  • 5Drazen JM,Arm JP,Austen KF.Sorting out the cytokines of asthma[J].J Exp Med,1996,183(1):1-5.
  • 6Kankaanranta H,Lindsay MA,Giembycz MA,et al.Delayed eosinophile apoptosis in asthma[J].J Allergy Clin Immunol,2000,106(1pt1):77-83.
  • 7Yousefi S,Hoessli DC,Blaser K,et al.Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosiophils[J].J Exp Med,1996,183(4):1407-1414.
  • 8Del Pozo V,Rojo M,Rubio ML,et al.Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation[J].Am J Respir Crit Care Med,2002,166(5):732-737.
  • 9Lopez E,Del Pozo V,Miguel T,et al.Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model[J].J Immunol,2006,176(3):1943-1950.
  • 10DEL POZO V,ROJO M L,RUBIO M L,et al.Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation[J].Am J Respir Crit Care Med,2002,166(5):732-737.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部